From the Journal

Use of the Impella Device for Acute Coronary Syndrome Complicated by Cardiogenic Shock – Experience From a Single Heart Center With Analysis of Long-term Mortality

Marco Robin Schroeter, MD1;  Herdis Köhler, DMD1;  Astrid Wachter, MSc2;  Annalen Bleckmann, MD2;  Gerd Hasenfuß, MD1;  Wolfgang Schillinger, MD1,3

Published online ahead of print on 2016 Aug 15

We screened our database of Impella patients in our heart center and found 68 consecutive patients who underwent Impella implantation due to acute coronary syndrome complicated by cardiogenic shock. Data were evaluated with regard to baseline and procedural characteristics and also included an assessment of the short-term and long-term outcomes....

Comparison Between Radial Approach and Femoral Approach With Vascular Closure Devices on the Occurrence of Access-Site Complications and Periprocedural Bleeding After Percutaneous Coronary Procedures: A Systematic Review and Meta-Analysis

Stefano Rigattieri, MD, PhD1;  Alessandro Sciahbasi, MD1;  Karim Ratib, MD2;  Alessandro Alonzo, MD3;  Nicholas Cox, MD4;  Piotr Chodór, MD5;  Andrea Berni, MD3;  Silvio Fedele, MD1;  Francesco R. Pugliese, MD1;  Christopher J. Cooper, MD6;  Yves Louvard, MD7;  James Nolan, MD2;  Sunil V. Rao, MD8

Published online ahead of print on 2016 Sep 15

We performed a systematic review and meta-analysis of available studies comparing the efficacy of radial access vs femoral access with hemostasis by vascular closure device on the reduction of access-site complications and/or periprocedural bleedings....

Right Heart Catheterization via Dialysis Arteriovenous Shunts in End-Stage Renal Disease Patients

Mu-Yang Hsieh, MD1;  Tsung-Yan Chen, MD1;  Lin Lin, MD1;  Min-Tsun Liao, MD1;  Ren-Huei Wang, RN1;  Ruei-Cheng Kuo, RT1;  Chao-Lun Lai, MD1,2,3,4,5;  Chih-Cheng Wu, MD1,3,4,6,7

Published online ahead of print on 2016 Sep 15

We evaluated the feasibility and safety of using dialysis AV shunts for access in right heart catheterization in 13 patients and found acceptable feasibility and patient tolerability. Further randomized studies are needed....

Near-Infrared Spectroscopy Analysis of Coronary Chronic Total Occlusions

Georgios E. Christakopoulos, MD;  Judit Karacsonyi, MD;  Barbara Anna Danek, MD;  Aris Karatasakis, MD;  Aya Alame, BS;  Pratik Kalsaria, BS;  Atif Mohammed, MD;  Michele Roesle, RN;  Bavana V. Rangan, BDS, MPH; Subhash Banerjee, MD;  Emmanouil S. Brilakis, MD, PhD1

A study on the presence and localization of lipid-core plaque in coronary vessels with chronic total occlusions using near-infrared spectroscopy....

Ahead of Print

Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve System

Kai-Uwe Jarr, MD;  Florian Leuschner, MD;  Benjamin Meder, MD;  Hugo A. Katus, MD;  Raffi Bekeredjian, MD; Emmanuel Chorianopoulos, MD

Published online ahead of print on 2016 Nov 15

An analysis of our first real-world experience with the second-generation, mechanically expanded, fully repositionable transfemoral Lotus TAVR device (Boston Scientific).

Periprocedural Myocardial Injury After Recanalization of Single Chronic Coronary Occlusion – A Propensity Score Analysis Comparing Long-Term Clinical Outcomes

Milosz Jaguszewski, MD, PhD1*;  Natasza Gilis-Malinowska, MD1*;  Juan Luis Gutierrez-Chico, MD, PhD2;  Michal Chmielecki, MD, PhD1;  Pawel Skarzynski, MD, PhD1;  Slawomir Burakowski, MD, PhD1;  Piotr Drewla, MD1; Radoslaw Targonski, MD, PhD3;  Lukasz Lewicki, MD, PhD3;  Witold Dubaniewicz, MD, PhD3;  Marcin Fijalkowski, MD, PhD1;  Marcin Gruchala, MD, PhD1;  Dariusz Ciecwierz, MD, PhD1


Published online ahead of print on 2016 Nov 15

Rates and importance of periprocedural myocardial injury (PMI) after crossing coronary CTOs is not well understood. This study sought to investigate long-term clinical implications of PMI in patients undergoing percutaneous coronary intervention for single CTO utilizing antegrade technique.

A Prospective Multicenter Study Using a Virtual 3 Fr Percutaneous Coronary Intervention System: The V3 Registry

Fuminobu Yoshimachi, MD, PhD1;  Yoshitoki Takagawa, MD, PhD2;  Hidenobu Terai, MD, PhD3;  Akihiko Takahashi, MD, PhD4;  Yoshihisa Shimada, MD, PhD5;  Takaaki Katsuki, MD, PhD6;  Satoru Tohara, MD, PhD7; Hiroshi Ueno, MD, PhD8;  Masanori Takada, MD, PhD9;  Nobuo Shiode, MD, PhD10;  Kunihiro Yamada, MD, PhD11; Noriyuki Kinoshita, MD, PhD12;  Tsuyoshi Honda, MD, PhD13;  Hiroshi Asano, MD, PhD14;  Satoshi Takeshita, MD, PhD15; Hiroaki Koiwa, MD, PhD16;  Tomoyasu Shin, MD17;  Motomaru Masutani, MD, PhD18;  Takashi Matsukage, MD, PhD19; Shigeru Saito, MD20;  Yuji Ikari, MD, PhD1 (V3 Registry Investigators)

Published online ahead of print on 2016 Jun 15

An evaluation of the safety and feasibility of virtual 3 Fr (V3), sheathless 5 Fr percutaneous coronary intervention.

Topic Center

News Wire

International Andreas
Gruentzig Society

Back to top